Literature DB >> 33427746

The Effect of Baseline Patient and Caregiver Mindfulness on Dementia Outcomes.

Ashley D Innis1, Magdalena I Tolea2, James E Galvin2.   

Abstract

BACKGROUND: Mindfulness is the practice of awareness and living in the present moment without judgment. Mindfulness-based interventions may improve dementia-related outcomes. Before initiating interventions, it would be beneficial to measure baseline mindfulness to understand targets for therapy and its influence on dementia outcomes.
OBJECTIVE: This cross-sectional study examined patient and caregiver mindfulness with patient and caregiver rating scales and patient cognitive performance and determined whether dyadic pairing of mindfulness influences patient outcomes.
METHODS: Individuals (N = 291) underwent comprehensive evaluations, with baseline mindfulness assessed using the 15-item Applied Mindfulness Process Scale (AMPS). Correlation, regression, and mediation models tested relationships between patient and caregiver mindfulness and outcomes.
RESULTS: Patients had a mean AMPS score of 38.0±11.9 and caregivers had a mean AMPS score of 38.9±11.5. Patient mindfulness correlated with activities of daily living, behavior and mood, health-related quality of life, subjective cognitive complaints, and performance on episodic memory and attention tasks. Caregiver mindfulness correlated with preparedness, care confidence, depression, and better patient cognitive performance. Patients in dyads with higher mindfulness had better cognitive performance, less subjective complaints, and higher health-related quality of life (all p-values<0.001). Mindfulness effects on cognition were mediated by physical activity, social engagement, frailty, and vascular risk factors.
CONCLUSION: Higher baseline mindfulness was associated with better patient and caregiver outcomes, particularly when both patients and caregivers had high baseline mindfulness. Understanding the baseline influence of mindfulness on the completion of rating scales and neuropsychological test performance can help develop targeted interventions to improve well-being in patients and their caregivers.

Entities:  

Keywords:  Alzheimer’s disease; dementia; inflammation; mild cognitive impairment; mindfulness

Year:  2021        PMID: 33427746      PMCID: PMC8324319          DOI: 10.3233/JAD-201292

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  89 in total

1.  Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study.

Authors:  Miia Kivipelto; Tiia Ngandu; Tiina Laatikainen; Bengt Winblad; Hilkka Soininen; Jaakko Tuomilehto
Journal:  Lancet Neurol       Date:  2006-09       Impact factor: 44.182

2.  Mindfulness training reduces loneliness and increases social contact in a randomized controlled trial.

Authors:  Emily K Lindsay; Shinzen Young; Kirk Warren Brown; Joshua M Smyth; J David Creswell
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-11       Impact factor: 11.205

3.  Mindfulness practice alters brain connectivity in community-living elders with mild cognitive impairment.

Authors:  Johnson Fam; Yu Sun; Peng Qi; Regine Cassandra Lau; Lei Feng; Ee Heok Kua; Rathi Mahendran
Journal:  Psychiatry Clin Neurosci       Date:  2020-01-25       Impact factor: 5.188

Review 4.  How do mindfulness-based cognitive therapy and mindfulness-based stress reduction improve mental health and wellbeing? A systematic review and meta-analysis of mediation studies.

Authors:  Jenny Gu; Clara Strauss; Rod Bond; Kate Cavanagh
Journal:  Clin Psychol Rev       Date:  2015-01-31

5.  The Cognitive Change Index as a Measure of Self and Informant Perception of Cognitive Decline: Relation to Neuropsychological Tests.

Authors:  Chatchawan Rattanabannakit; Shannon L Risacher; Sujuan Gao; Kathleen A Lane; Steven A Brown; Brenna C McDonald; Frederick W Unverzagt; Liana G Apostolova; Andrew J Saykin; Martin R Farlow
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

6.  Predicting cognitive decline: a dementia risk score vs. the Framingham vascular risk scores.

Authors:  Sara Kaffashian; Aline Dugravot; Alexis Elbaz; Martin J Shipley; Séverine Sabia; Mika Kivimäki; Archana Singh-Manoux
Journal:  Neurology       Date:  2013-04-02       Impact factor: 9.910

7.  Construct and concurrent validity of the Hopkins Verbal Learning Test-revised.

Authors:  A M Shapiro; R H Benedict; D Schretlen; J Brandt
Journal:  Clin Neuropsychol       Date:  1999-08       Impact factor: 3.535

8.  Meditation for adults with mild cognitive impairment: a pilot randomized trial.

Authors:  Rebecca Erwin Wells; Catherine E Kerr; Jennifer Wolkin; Michelle Dossett; Roger B Davis; Jacquelyn Walsh; Robert B Wall; Jian Kong; Ted Kaptchuk; Daniel Press; Russell S Phillips; Gloria Yeh
Journal:  J Am Geriatr Soc       Date:  2013-04       Impact factor: 5.562

9.  Mindfulness in the Maintenance of Cognitive Capacities in Alzheimer's Disease: A Randomized Clinical Trial.

Authors:  Domingo J Quintana-Hernández; María T Miró-Barrachina; Ignacio J Ibáñez-Fernández; Angelo Santana-Del Pino; María P Quintana-Montesdeoca; Bienvenida Rodríguez-de Vera; David Morales-Casanova; María Del Carmen Pérez-Vieitez; Javier Rodríguez-García; Noelia Bravo-Caraduje
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

Review 10.  Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.

Authors:  Ian G McKeith; Bradley F Boeve; Dennis W Dickson; Glenda Halliday; John-Paul Taylor; Daniel Weintraub; Dag Aarsland; James Galvin; Johannes Attems; Clive G Ballard; Ashley Bayston; Thomas G Beach; Frédéric Blanc; Nicolaas Bohnen; Laura Bonanni; Jose Bras; Patrik Brundin; David Burn; Alice Chen-Plotkin; John E Duda; Omar El-Agnaf; Howard Feldman; Tanis J Ferman; Dominic Ffytche; Hiroshige Fujishiro; Douglas Galasko; Jennifer G Goldman; Stephen N Gomperts; Neill R Graff-Radford; Lawrence S Honig; Alex Iranzo; Kejal Kantarci; Daniel Kaufer; Walter Kukull; Virginia M Y Lee; James B Leverenz; Simon Lewis; Carol Lippa; Angela Lunde; Mario Masellis; Eliezer Masliah; Pamela McLean; Brit Mollenhauer; Thomas J Montine; Emilio Moreno; Etsuro Mori; Melissa Murray; John T O'Brien; Sotoshi Orimo; Ronald B Postuma; Shankar Ramaswamy; Owen A Ross; David P Salmon; Andrew Singleton; Angela Taylor; Alan Thomas; Pietro Tiraboschi; Jon B Toledo; John Q Trojanowski; Debby Tsuang; Zuzana Walker; Masahito Yamada; Kenji Kosaka
Journal:  Neurology       Date:  2017-06-07       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.